| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
AAV-mediated gene therapy for sialidosis
|
van de Vlekkert, Diantha
|
|
|
32 |
7 |
p. 2094-2112
|
article
|
| 2 |
AAV vectors for long-term gene therapy of hemophilia B: Are we there yet?
|
Srivastava, Arun
|
|
|
32 |
7 |
p. 2042-2044
|
article
|
| 3 |
A functional RNA-origami as direct thrombin inhibitor with fast-acting and specific single-molecule reversal agents in vivo model
|
Krissanaprasit, Abhichart
|
|
|
32 |
7 |
p. 2286-2298
|
article
|
| 4 |
A new MVA ancestor-derived oncolytic vaccinia virus induces immunogenic tumor cell death and robust antitumor immune responses
|
Rojas, Juan J.
|
|
|
32 |
7 |
p. 2406-2422
|
article
|
| 5 |
A “one size fits all” gene therapy for neurological disorders with mitochondrial dysfunction
|
Ling, Qinglan
|
|
|
32 |
7 |
p. 2045-2046
|
article
|
| 6 |
A promising advance in blocking HTLV-1 transmission: Addressing a global public health problem
|
Rosário Vallinoto, Antonio Carlos
|
|
|
32 |
7 |
p. 2050-2051
|
article
|
| 7 |
ASGCT 2024: Navigating the sea of gene and cell therapies
|
Herzog, Roland W.
|
|
|
32 |
7 |
p. 2037
|
article
|
| 8 |
Carbon monoxide-induced autophagy enhances human mesenchymal stromal cell function via paracrine actions in murine polymicrobial sepsis
|
Hwang, Narae
|
|
|
32 |
7 |
p. 2232-2247
|
article
|
| 9 |
Carbon monoxide licensing of MSCs enhances their efficacy through autophagy-mediated miRNA mechanisms
|
Dunbar, Hazel
|
|
|
32 |
7 |
p. 2047-2049
|
article
|
| 10 |
Chandipura viral glycoprotein (CNV-G) promotes Gectosome generation and enables delivery of intracellular therapeutics
|
Zhang, Xiaojuan
|
|
|
32 |
7 |
p. 2264-2285
|
article
|
| 11 |
Chopping down antibodies for a good cause
|
Biswas, Moanaro
|
|
|
32 |
7 |
p. 2040-2041
|
article
|
| 12 |
Clinical immunogenicity outcomes from GENEr8-1, a phase 3 study of valoctocogene roxaparvovec, an AAV5-vectored gene therapy for hemophilia A
|
Long, Brian R.
|
|
|
32 |
7 |
p. 2052-2063
|
article
|
| 13 |
Correlation of antigen expression with epigenetic modifications after rAAV delivery of a human factor IX variant in mice and rhesus macaques
|
Pekrun, Katja
|
|
|
32 |
7 |
p. 2064-2079
|
article
|
| 14 |
Development of an mRNA-based therapeutic vaccine mHTV-03E2 for high-risk HPV-related malignancies
|
Wang, Jing
|
|
|
32 |
7 |
p. 2340-2356
|
article
|
| 15 |
Dual-aptamer-engineered M1 macrophage with enhanced specific targeting and checkpoint blocking for solid-tumor immunotherapy
|
Qian, Husun
|
|
|
32 |
7 |
p. 2423-2424
|
article
|
| 16 |
Engineered IgM and IgG cleaving enzymes for mitigating antibody neutralization and complement activation in AAV gene transfer
|
Smith, Timothy J.
|
|
|
32 |
7 |
p. 2080-2093
|
article
|
| 17 |
Engineering of potent CAR NK cells using non-viral Sleeping Beauty transposition from minimalistic DNA vectors
|
Bexte, Tobias
|
|
|
32 |
7 |
p. 2357-2372
|
article
|
| 18 |
Evaluation of [18F]fluoroestradiol and ChRERα as a gene expression PET reporter system in rhesus monkey brain
|
Li, Bing
|
|
|
32 |
7 |
p. 2223-2231
|
article
|
| 19 |
Gene therapy for Lafora disease in the Epm2a −/− mouse model
|
Zafra-Puerta, Luis
|
|
|
32 |
7 |
p. 2130-2149
|
article
|
| 20 |
GLUT1 overexpression enhances CAR T cell metabolic fitness and anti-tumor efficacy
|
Shi, Yuzhe
|
|
|
32 |
7 |
p. 2393-2405
|
article
|
| 21 |
Granzyme B-activated IL18 potentiates αβ and γδ CAR T cell immunotherapy in a tumor-dependent manner
|
Hull, Caroline M.
|
|
|
32 |
7 |
p. 2373-2392
|
article
|
| 22 |
In this issue
|
|
|
|
32 |
7 |
p. 2038-2039
|
article
|
| 23 |
In vivo adenine base editing rescues adrenoleukodystrophy in a humanized mouse model
|
Gopalappa, Ramu
|
|
|
32 |
7 |
p. 2190-2206
|
article
|
| 24 |
Neuroglobin overexpression in cerebellar neurons of Harlequin mice improves mitochondrial homeostasis and reduces ataxic behavior
|
Cwerman-Thibault, Hélène
|
|
|
32 |
7 |
p. 2150-2175
|
article
|
| 25 |
Perinatal loss of galactosylceramidase in both oligodendrocytes and microglia is crucial for the pathogenesis of Krabbe disease in mice
|
Favret, Jacob
|
|
|
32 |
7 |
p. 2207-2222
|
article
|
| 26 |
Prophylactic vaccination inducing anti-Env antibodies can result in protection against HTLV-1 challenge in macaques
|
Nakamura-Hoshi, Midori
|
|
|
32 |
7 |
p. 2328-2339
|
article
|
| 27 |
Retraction Notice to: Long Noncoding RNA LINC00673 Is Activated by SP1 and Exerts Oncogenic Properties by Interacting with LSD1 and EZH2 in Gastric Cancer
|
Huang, Mingde
|
|
|
32 |
7 |
p. 2425
|
article
|
| 28 |
Retraction Notice to: The Pseudogene DUXAP8 Promotes Non-small-cell Lung Cancer Cell Proliferation and Invasion by Epigenetically Silencing EGR1 and RHOB
|
Sun, Ming
|
|
|
32 |
7 |
p. 2426
|
article
|
| 29 |
Single-shot dendritic cell targeting SARS-CoV-2 vaccine candidate induces broad, durable and protective systemic and mucosal immunity in mice
|
Cheang, Nicholas You Zhi
|
|
|
32 |
7 |
p. 2299-2315
|
article
|
| 30 |
Targeted rescue of synaptic plasticity improves cognitive decline in sepsis-associated encephalopathy
|
Grünewald, Benedikt
|
|
|
32 |
7 |
p. 2113-2129
|
article
|
| 31 |
Tat-dependent conditionally replicating adenoviruses expressing diphtheria toxin A for specifically killing HIV-1-infected cells
|
Ni, Fengfeng
|
|
|
32 |
7 |
p. 2316-2327
|
article
|
| 32 |
The MuSK agonist antibody protects the neuromuscular junction and extends the lifespan in C9orf72-ALS mice
|
Sun, Shuangshuang
|
|
|
32 |
7 |
p. 2176-2189
|
article
|
| 33 |
The novel potential therapeutic target PSMP/MSMP promotes acute kidney injury via CCR2
|
Song, Zhanming
|
|
|
32 |
7 |
p. 2248-2263
|
article
|
Journal description